Comprehensive gene-expression profile in murine oxygen-induced retinopathy

British Journal of Ophthalmology

Volumn 93, Issue 1, 2009, Pages 96-103

  Sato, T ^a   Kusaka, S ^a   Hashida, N ^a   Saishin, Y ^a   Fujikado, T ^a   Tano, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 2; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; OXYGEN; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; GENE EXPRESSION PROFILING; GENETIC ASSOCIATION; GENETIC CORRELATION; INFLAMMATION; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RETINA NEOVASCULARIZATION; RETROLENTAL FIBROPLASIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VASOCONSTRICTION;

ANIMALS; ANIMALS, NEWBORN; CORNEAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; GENE EXPRESSION; GENE EXPRESSION PROFILING; MICE; MICE, INBRED C57BL; OXYGEN; RETINAL DISEASES; RETINAL NEOVASCULARIZATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 58349095562     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2008.142646     Document Type: Article

References (27)

1. Terry TL. Fibroblastic overgrowth of persistent tunica vasculosa lentis in infants born prematurely: II. Report of cases-clinical aspects. Trans Am Ophthalmol Soc 1942;40:262-84.
2. Mechoulam H, Pierce EA. Retinopathy of prematurity: molecular pathology and therapeutic strategies. Am J Pharmacogenomics 2003;3:261-77.
3. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis 2007;10:133-40.
4. Smith LE, Wesolowski E, McLellan A, et al. Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 1994;35:101- 11.
5. Aiello LP, Pierce EA, Foley ED, et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 1995;92:10457-61.
6. Higgins RD, Yu K, Sanders RJ, et al. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr Eye Res 1999;18:20-7.
7. Yossuck P, Yan Y, Tadesse M, et al. Dexamethasone and critical effect of timing on retinopathy. Invest Ophthalmol Vis Sci 2000;41:3095-9.
8. Miyamoto N, Mandai M, Takagi H, et al. Contrasting effect of estrogen on VEGF induction under different oxygen status and its role in murine ROP. Invest Ophthalmol Vis Sci 2002;43:2007-14.
9. Oh H, Takagi H, Otani A, et al. Selective induction of neuropilin-1 by vascular endothelial growth factor (VEGF): a mechanism contributing to VEGF-induced angiogenesis. Proc Natl Acad Sci USA 2002;99:383-8.
10. Takagi H, Koyama S, Seike H, et al. Potential role of the angiopoietin Aie 2 system in ischemia-induced retinal neovascularization. Invest Ophthalmol Vis Sci 2003;44:393-402.
11. Yoshida S, Yoshida A, Ishibashi T, et al. Role of MCP-1 and MIP-1α in retinal neovascularization during postischemic inflammation in a mouse model of retinal neovascularization. J Leukoc Biol 2003;73:137-44.
12. Agostini H, Boden K, Unsold A, et al. A single local injection of recombinant VEGF receptor 2 but not of Tie2 inhibits retinal neovascularization in the mouse. Curr Eye Res 2005;30:249-57.
13. Nagai N, Noda K, Urano T, et al. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Invest Ophthalmol Vis Sci 2005;46:1078-84.
14. Spandau UH, Sauder G, Schubert U, et al. Effect of triamcinolone acetonide on proliferative of retinal endothelial cells in vitro and in vivo. Br J Ophthalmol 2005;89:745-7.
15. Zamora DO, Davies MH, Planck SR, et al. Soluble forms of Ephrin B2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy. Invest Ophthalmol Vis Sci 2005;46:2175- 82.
16. Zhang M, Yang Y, Yan M, et al. Downregulation of vascular endothelial growth factor and integrin β3 by endostatin in a mouse model of retinal neovascularization. Exp Eye Res 2006;82:74-80.
17. Konopatskaya O, Churchill AJ, Harper SJ, et al. VEGF165b, an endogenous C- terminal splice variant of VEGF, inhibits retinal neovascularization in mice. Mol Vis 2006;12:626-32.
18. Kociok N, Krohne TU, Poulaki V, et al. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Graeie's Arch Clin Exp Ophthalmol 2007;245:258-66.
19. Stag A, Wang W, Blanquicett C, et al. Multiple gene expression analyses in paraffinembedded tissues by TaqMan low-density array: Application to hedgehog and Wnt pathway analysis in ovarian endometrioid adenocarcinoma. J Mol Diagn 2006;8:76-83.
20. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxia-inducible factor 1. Crit Rev Oncol Hematol 2006;59:15-26.
21. An International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005;3:991-9.
22. Su SJ, Yeh TM, Chuang WJ, et al. The novel targets for anti-angiogenesis of genistein on human cancer cells. Biochem Pharmacol 2005;69:307-18.
23. Dass K, Ahmad A, Azmi AS, et al. Evolving role of uPA/uPAR system in human cancers. Cancer Treat Rev 2008;34:122-36.
24. Yoshida S, Yoshida A, Ishibashi T. Induction of IL-8, MCP-1, and bFGF by TNF-α in retinal glial cells: implications for retinal neovascularization during post-ischemic inflammation. Graefe's Arch Clin Exp Ophthalmol 2004;242:409-13.
25. Hartnett ME, Martiniuk DJ, Saito Y, et al. Triamcinolone reduces neovascularization, capillary density and IGF-1 receptor phosphorylation in a model of oxygen-induced retinopathy. Invest Ophthalmol Vis Sci 2006;47:4975-82.
26. Penn JS, Rajaratnam VS, Collier RJ, et al. The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity. Invest Ophthalmol Vis Sci 2001;42:283-90.
27. Ishihama H, Ohbayashi M, Kurosawa N, et al. Colocalization of neuropilin-1 and Flk-1 in retinal neovascularization in a mouse model of retinopathy. Invest Ophthalmol Vis Sci 2001;42:1172-8.